Sponsored
by Takara Bio
Combination Therapies: Opportunities for Improved CAR-T Cell Therapy?
Chimeric antigen receptor (CAR) cell therapy offers hope where other cancer therapies have failed. However,…
03/11/2021 - 6 minutes
Alexander Burik
Born in Chicago, I grew up close to Frankfurt, Germany. I hold an MSc in Neuroscience from University College London and a BA in Biochemistry from Knox College in the US.
Outside of science-related activities, I enjoy skiing and writing music.
Sponsored
by Charles River
Artificial Intelligence: A Road to Faster and Better Drug Discovery?
Artificial intelligence (AI) has become a part of everyday modern life and continues to generate…
28/09/2021 - 6 minutes
Seven Tips to Succeed in Pharma-Biotech Partnerships
The question of whether to partner with another company is critical to the long-term development…
09/03/2020 - 8 minutes
Update: Swedish Medical Device Fails to Treat Spinal Cord Injury
Update (21/11/2019): The Swedish biotech BioArctic has terminated the clinical development of a biodegradable implant…
21/11/2019 - 3 minutes
Update: Series A Boost Pushes Belgian Microbiome Spin-Off Forward
Update (27/09/2018): New investment from Dutch venture capital fund Innovation Industries brings A-Mansia's Series A…
27/09/2018 - 2 minutes
Update: Non-Invasive Glucose Monitoring Device Moves Forward With Series B Funding
Update (10/09/2018): RSP Systems has raised an additional €3.85M that raises the total amount of…
10/09/2018 - 2 minutes
Novo Nordisk Buys British ‘Smart’ Insulin Diabetes Biotech in deal worth €702M
Novo Nordisk acquired the UK biotech Ziylo, which develops glucose-responsive insulin treatments for diabetes that…
17/08/2018 - 2 minutes
This Italian Biotech Makes Wood-Derived Bone Implants
Today, we’re in Faenza, Italy, visiting GreenBone, a biotech developing wood-derived bone implants for patients…
17/08/2018 - 2 minutes
Pfizer Offers €374M for German mRNA Flu Vaccine
BioNTech, based in Mainz, Germany, has entered into a partnership with Pfizer worth up to…
16/08/2018 - 2 minutes
London Biotech Gets Positive Phase III Results for its Monthly HIV Treatment
ViiV Healthcare has shown its monthly two-drug HIV treatment works as well as a daily…
15/08/2018 - 2 minutes
Orchard Therapeutics Raises €132M to Develop Gene Therapies
Orchard Therapeutics raised $150M (€132M) in Series C financing to bring its gene therapies from…
13/08/2018 - 2 minutes
UK Biotech Raises €73M to Target DNA Repair in Treating Cancer
Artios Pharma completed a €73M (£65M) Series B financing round to develop cancer treatments that…
10/08/2018 - 3 minutes
